Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
What does an index reading tell you about the market? It reflects price action and momentum, offering clues to potential trends and turning points.
28,481 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Roundhill's DRAM ETF, with a 49% Korea weighting, has surged but faces overnight gaps as half its holdings trade when...
A veteran market strategist argues Big Tech is underappreciated as earnings grow and capital spending remains durable...
Two discount retailers face off for 2026 returns, with Dollar Tree highlighting a store-format push and Dollar Genera...
As U.S. Treasury yields climb, the tax advantages of municipal bonds are under fresh scrutiny. High-income investors ...
Two blue-chip banks report divergent 2026 results: Morgan Stanley leans on wealth advisory, while JPMorgan runs a uni...
Bitcoin Everlight has begun an open presale for its Everlight Shards, a participation layer atop a distributed valida...
Intuitive Machines led a mixed day in space stocks, rising about 9% as rivals eased back in a rotation-focused market...
A growing number of seniors are eyeing The Woodlands, Texas, as a retirement hub on a $1.1 million portfolio. The pla...
Markets toppled and surged in swings as investors assessed a policy path that some say appears improvised. Analysts w...
As investors seek durable AI upside beyond chips, three ETFs focusing on the software layer beat peers and promise re...
Palo Alto Networks has surged about a month’s worth of gains, fueling a debate on whether to book profits and rotate ...